Treatment
Medication clinical trials
We’re tracking 7,458 recruiting studies that include Medication, each written for real people, not researchers, below.
Recruiting studies
- NCT05989698Recruiting
Validating a wearable cough monitor (C-mo)
This study tests a wearable device (C-mo) that monitors coughing. It is for people of all ages who are currently coughing and can cooperate with wearing a small sensor on their belly for a short time.
AlfenaAges 2 years+ - NCT05990790RecruitingPhase 4
Comparing anesthetics and their effect on confusion after surgery
This study compares three different anesthesia medicines to see which one might lower the chance of confusion or delirium after major surgery. If you are 65 or older and having a long, planned non-heart surgery, this trial could help determine the safest option for you.
InnsbruckAges 65 years+ - NCT05990491Recruiting
Pituitary function after recovery from septic shock in ICU survivors
This study checks how well the pituitary gland (a small gland in your brain that controls hormones) works after you recover from a severe infection that caused dangerously low blood pressure (septic shock). It aims to see if the gland was affected during your ICU stay.
Lucknow, Uttar PradeshAges 18–80 - NCT05992220RecruitingPhase 2
Immunotherapy with or without radiation for liver cancer
This trial tests a combination of two immunotherapy drugs (atezolizumab and bevacizumab) with or without targeted radiation therapy for liver cancer that has invaded the major blood vessels of the liver. The goal is to see if adding radiation helps shrink tumors or slow the disease.
SeoulAges 20–79 - NCT05992363Recruiting
Comparing stents for malignant ureteral blockage
This trial tests whether using two newer stents (Tandem Polyurethane) works better than the standard single silicone stent for people whose urine tubes are blocked by cancer. The goal is to improve urine flow and relieve discomfort.
Petah TikvaAges 18 years+ - NCT05992584RecruitingPhase 2
Lenvatinib, sintilimab, and SIRT for liver cancer
This trial tests a combination of two drugs (lenvatinib and sintilimab) plus a procedure called SIRT (radioactive beads) for people with liver cancer that can't be surgically removed. The goal is to see if this triple approach works better than standard treatments.
Guangzhou, GuangdongAges 18–75 - NCT05992831Recruiting
Transcranial magnetic stimulation for mild cognitive impairment
This trial tests whether transcranial magnetic stimulation (a noninvasive brain stimulation technique) can help people with mild cognitive impairment (MCI). You and a close contact, like a spouse or friend, will both take part in the study over several sessions.
Charleston, South CarolinaAges 60–85 - NCT05993221Recruiting
Understanding arm weakness after stroke
This study looks at the brain changes that happen after a stroke and how they affect arm movement. It uses MRI scans and gentle magnetic pulses to understand your brain better, which may help guide future treatments.
Providence, Rhode IslandAges 18–90 - NCT05994859Recruiting
SIRT for potentially removable liver cancer
This trial tests a targeted radiation treatment (SIRT) for people with liver cancer that is still confined to one side of the liver and has not been treated before. The goal is to see if SIRT can shrink the tumor enough to make surgical removal possible.
Guangzhou, GuangdongAges 18–75 - NCT05995951Recruiting
Deep brain stimulation for severe OCD
This trial tests whether deep brain stimulation (a surgical implant that sends electrical pulses to part of your brain) can help people with severe obsessive-compulsive disorder (OCD) that has not improved with standard treatments.
Petah TikvaAges 18–75 - NCT05996016Recruiting
Gut and vaginal bacteria in HIV-positive women
This study looks at the types of bacteria living in the gut and vagina of women with HIV, including pregnant women. It aims to understand how these bacteria might affect health.
Beijing, Beijing MunicipalityAges 14 years+ - NCT05997992Recruiting
Electroacupuncture for overactive bladder in women
This study tests whether adding electroacupuncture (a type of acupuncture with mild electrical pulses) to usual care can help control overactive bladder symptoms in women. If you are a woman aged 20–80 with overactive bladder and haven't tried certain treatments before, you may be eligible.
New Taipei CityAges 20–80 - NCT05998629Recruiting
Sweat sensor test for cystic fibrosis
This trial tests a new skin sensor that measures sweat to help diagnose cystic fibrosis. It compares results from people with CF and healthy volunteers to see if the device works accurately.
Hershey, PennsylvaniaAges 18–80 - NCT05998928RecruitingPhase 2
BCMA-GPRC5D CAR-T for relapsed or refractory multiple myeloma
This trial tests a new cell therapy (CAR-T) that targets two proteins on myeloma cells for patients whose cancer has returned or not responded after at least three prior treatments. It aims to see if this therapy is safe and effective.
Wuhan, HubeiAges 18–75 - NCT05999630RecruitingPhase 3
Artificial tears to prevent tear duct blockage during RAI therapy
This study tests if using artificial tears (eye drops that keep your eyes moist) can prevent tear duct blockage in people receiving high-dose radioactive iodine for thyroid cancer. If you qualify, you will use artificial tears during your treatment to see if they help keep your tear ducts open.
Nashville, TennesseeAges 18 years+ - NCT06000917RecruitingPhase 2
Study of combination therapy before surgery for ER+/HER2+ breast cancer
This trial tests a combination of targeted therapies and chemotherapy given before surgery for women with a specific type of breast cancer that is both ER-positive and HER2-positive. The goal is to see if this treatment can shrink tumors and improve outcomes.
Wuhan, HubeiAges 18–75 - NCT06001086RecruitingPhase 2
Disitamab Vedotin plus Pyrotinib for HER2-positive early breast cancer
This trial tests a combination of two targeted drugs (Disitamab Vedotin and Pyrotinib) for people with HER2-positive early breast cancer. It aims to see if this treatment can improve outcomes before standard therapy.
Nanjing, JiangsuAges 18 years+ - NCT06001736Recruiting
Nerve transfer surgery for arm weakness after stroke
This study tests a surgery called CC7 transfer, where a nerve from your healthy side is moved to help your weaker arm. It is for people whose arm has stopped getting better after a stroke and still has significant weakness.
Lebanon, New HampshireAges 18–65 - NCT06001918RecruitingPhase 2/Phase 3
Testing a new aneurysm treatment device
This trial tests a new device (Nectero EAST) for treating abdominal aortic aneurysms without major surgery. It may be an option for people with a medium-size aneurysm who have not had prior repair.
Scottsdale, ArizonaAges 21–85 - NCT06003348RecruitingPhase 4
Can a supplement help prevent calcium phosphate kidney stones?
This study tests a supplement called hydroxycitrate to see if it can help people who form calcium phosphate kidney stones. It may offer a new way to prevent stones from forming.
Dallas, TexasAges 21–99 - NCT06003192Recruiting
Screen Smart: Boosting HIV testing in teens
This trial tests a digital health tool to help increase HIV screening and prevention among teenagers visiting the emergency department. If you are 15 to 21 years old, you may be able to join and help improve how we offer these services.
Columbus, OhioAges 15–21 - NCT06003634Recruiting
Peer Support for Type 2 Diabetes in Rural Kentucky
This study tests whether having a trained peer coach (a person who also has diabetes) can help older adults in rural Kentucky better manage their Type 2 Diabetes. If you join, you'll get support from someone who understands your experience.
Bowling Green, KentuckyAges 55 years+ - NCT06006832Recruiting
A Study of Myasthenia Gravis in China
This study follows people with myasthenia gravis who are patients at Peking Union Medical College Hospital to learn more about the disease and how it affects patients over time.
Beijing, Beijing MunicipalityAges 18 years+ - NCT06006637Recruiting
Measuring and reducing autism symptoms
This study tests a new platform designed to measure and reduce autism symptoms in children ages 2 to 8. It may help if your child has an autism diagnosis and is not taking psychiatric medications.
New York, New YorkAges 2–8
Common questions
- Are there clinical trials studying Medication?
- Yes. Clin2 currently lists 7,458 recruiting studies that include Medication, drawn from the U.S. registry and rewritten for real people so you can see what each is testing and who it's for.
- How do I know if I qualify for a Medication trial?
- Each study lists its own eligibility criteria — rules about condition, age, and prior treatments. On every Clin2 trial page we explain these in plain language and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Is Medication an approved treatment?
- A drug being studied in a trial may be investigational (still being tested) or already approved and being studied for a new use. Each study page explains what phase it's in. Clin2 does not provide medical advice — talk with your doctor about whether Medication or a specific trial is right for you.
Related treatments
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. A drug appearing here is being studied in a trial and may be investigational. Talk with your doctor about whether a specific treatment or trial is right for you.